Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Masahide Kuroki

Department of Biochemistry

Faculty of Medicine

Fukuoka University

Fukuoka

Japan

[email]@fukuoka-u.ac.jp

Name/email consistency: high

[Claim this account]

Affiliations

Department of Biochemistry, Faculty of Medicine, Fukuoka University, Fukuoka, Japan. 2007
First Department of Biochemistry, Fukuoka University School of Medicine, 7-45-1 Nanakuma, Jonan-ku, Japan. 2000 - 2006

References

Sonodynamic therapy of cancer using novel sonosensitizers. Kuroki, M., Hachimine, K., Abe, H., Shibaguchi, H., Kuroki, M., Maekawa, S., Yanagisawa, J., Kinugasa, T., Tanaka, T., Yamashita, Y. Anticancer Res. (2007) [Pubmed]
Possible applications of antibodies or their genes in cancer therapy. Kuroki, M., Huang, J., Shibaguchi, H., Tanaka, T., Zhao, J., Luo, N., Hachimine, K., Kinugasa, T., Maekawa, S., Enatsu, S., Hamanaka, W., Fukami, T., Kuroki, M. Anticancer Res. (2006) [Pubmed]
Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity. Kuroki, M., Hachimine, K., Huang, J., Shibaguchi, H., Kinugasa, T., Maekawa, S., Kuroki, M. Anticancer Res. (2005) [Pubmed]
Tumor-targeting of viral vectors for cancer gene therapy by using antibodies or their genes against tumor-associated antigens. Kuroki, M., Kuroki, M., Shibaguchi, H., Hachimine, K., Kinugasa, T., Badran, A. Anticancer Res. (2004) [Pubmed]
Strategies to endow cytotoxic T lymphocytes or natural killer cells with antibody activity against carcinoembryonic antigen. Kuroki, M., Kuroki, M., Shibaguchi, H., Badran, A., Hachimine, K., Zhang, J., Kinugasa, T. Tumour Biol. (2004) [Pubmed]
Immunotherapy and gene therapy of cancer using antibodies or their genes against tumor-associated antigens. Kuroki, M., Shibaguchi, H., Imakiire, T., Uno, K., Shirota, K., Higuchi, T., Shitama, T., Yamada, H., Hirose, Y., Nagata, A., Kuroki, M. Anticancer Res. (2003) [Pubmed]
Significance of tumor-associated antigens in the diagnosis and therapy of cancer: an overview. Kuroki, M., Ueno, A., Matsumoto, H., Abe, H., Li, T., Imakiire, T., Yamauchi, Y., Uno, K., Shirota, K., Shibaguchi, H., Kuroki, M. Anticancer Res. (2002) [Pubmed]
Specific targeting strategies of cancer gene therapy using a single-chain variable fragment (scFv) with a high affinity for CEA. Kuroki, M., Arakawa, F., Khare, P.D., Kuroki, M., Liao, S., Matsumoto, H., Abe, H., Imakiire, T. Anticancer Res. (2000) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.